Human Eukaryotic Release Factor 3a Depletion Causes Cell Cycle Arrest at G₁ Phase through Inhibition of the mTOR Pathway

REFERENCES

• Barbet, N. C., U. Schneider, S. B. Helliwell, I. Stansfield, M. F. Tuite, and M. N. Hall. 1996. TOR controls translation initiation and early G1 progression in yeast. Mol. Biol. Cell 7:25–42.
   PubMed Web of Science ®Google Scholar
• Basu, J., B. C. Williams, Z. Li, E. V. Williams, and M. L. Goldberg. 1998. Depletion of a Drosophila homolog of yeast Sup35p disrupts spindle assembly, chromosome segregation, and cytokinesis during male meiosis. Cell Motil. Cytoskeleton 39:286–302.
   PubMedGoogle Scholar
• Borchsenius, A. S., A. A. Tchourikova, and S. G. Inge-Vechtomov. 2000. Recessive mutations in SUP35 and SUP45 genes coding for translation release factors affect chromosome stability in Saccharomyces cerevisiae. Curr. Genet. 37:285–291.
   PubMedGoogle Scholar
• Brito, M., J. Malta-Vacas, B. Carmona, C. Aires, P. Costa, A. P. Martins, S. Ramos, A. R. Conde, and C. Monteiro. 2005. Polyglycine expansions in eRF3/GSPT1 are associated with gastric cancer susceptibility. Carcinogenesis 26:2046–2049.
   PubMed Web of Science ®Google Scholar
• Carnes, J., M. Jacobson, L. Leinwand, and M. Yarus. 2003. Stop codon suppression via inhibition of eRF1 expression. RNA 9:648–653.
   PubMed Web of Science ®Google Scholar
• Chauvin, C., S. Salhi, C. Le Goff, W. Viranaicken, D. Diop, and O. Jean-Jean. 2005. Involvement of human release factors eRF3a and eRF3b in translation termination and regulation of the termination complex formation. Mol. Cell. Biol. 25:5801–5811.
   PubMed Web of Science ®Google Scholar
• Chavatte, L., L. Frolova, L. Kisselev, and A. Favre. 2001. The polypeptide chain release factor eRF1 specifically contacts the s(4)UGA stop codon located in the A site of eukaryotic ribosomes. Eur. J. Biochem. 268:2896–2904.
   PubMedGoogle Scholar
• Corradetti, M. N., and K. L. Guan. 2006. Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? Oncogene 25:6347–6360.
   PubMed Web of Science ®Google Scholar
• Cosson, B., N. Berkova, A. Couturier, S. Chabelskaya, M. Philippe, and G. Zhouravleva. 2002. Poly(A)-binding protein and eRF3 are associated in vivo in human and Xenopus cells. Biol. Cell 94:205–216.
   PubMed Web of Science ®Google Scholar
• Cowley, S., H. Paterson, P. Kemp, and C. J. Marshall. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841–852.
   PubMed Web of Science ®Google Scholar
• Diop, D., C. Chauvin, and O. Jean-Jean. 2007. Aminoglycosides and other factors promoting stop codon readthrough in human cells. C. R. Biol. 330:71–79.
   PubMedGoogle Scholar
• Frolova, L., X. Le Goff, H. H. Rasmussen, S. Cheperegin, G. Drugeon, M. Kress, I. Arman, A. L. Haenni, J. E. Celis, M. Philippe, J. Justesen, and L. Kisselev. 1994. A highly conserved eukaryotic protein family possessing properties of polypeptide chain release factor. Nature 372:701–703.
   PubMed Web of Science ®Google Scholar
• Frolova, L., X. Le Goff, G. Zhouravleva, E. Davydova, M. Philippe, and L. Kisselev. 1996. Eukaryotic polypeptide chain release factor eRF3 is an eRF1- and ribosome-dependent guanosine triphosphatase. RNA 2:334–341.
   PubMed Web of Science ®Google Scholar
• Gielkens, A. L., T. J. Berns, and H. Bloemendal. 1971. An efficient procedure for the isolation of polyribosomes from tissue culture. Eur. J. Biochem. 22:478–484.
   PubMedGoogle Scholar
• Hanic-Joyce, P. J., G. C. Johnston, and R. A. Singer. 1987. Regulated arrest of cell proliferation mediated by yeast prt1 mutations. Exp. Cell Res. 172:134–145.
   PubMedGoogle Scholar
• Hauryliuk, V., A. Zavialov, L. Kisselev, and M. Ehrenberg. 2006. Class-1 release factor eRF1 promotes GTP binding by class-2 release factor eRF3. Biochimie 88:747–757.
   PubMedGoogle Scholar
• Hay, N., and N. Sonenberg. 2004. Upstream and downstream of mTOR. Genes Dev. 18:1926–1945.
   PubMed Web of Science ®Google Scholar
• Horrevoets, A. J., R. D. Fontijn, A. J. van Zonneveld, C. J. de Vries, J. W. ten Cate, and H. Pannekoek. 1999. Vascular endothelial genes that are responsive to tumor necrosis factor-alpha in vitro are expressed in atherosclerotic lesions, including inhibitor of apoptosis protein-1, stannin, and two novel genes. Blood 93:3418–3431.
   PubMedGoogle Scholar
• Hoshino, S., M. Imai, T. Kobayashi, N. Uchida, and T. Katada. 1999. The eukaryotic polypeptide chain releasing factor (eRF3/GSPT) carrying the translation termination signal to the 3′-poly(A) tail of mRNA. Direct association of eRF3/GSPT with polyadenylate-binding protein. J. Biol. Chem. 274:16677–16680.
   PubMed Web of Science ®Google Scholar
• Hoshino, S., M. Imai, M. Mizutani, Y. Kikuchi, F. Hanaoka, M. Ui, and T. Katada. 1998. Molecular cloning of a novel member of the eukaryotic polypeptide chain-releasing factors (eRF). Its identification as eRF3 interacting with eRF1. J. Biol. Chem. 273:22254–22259.
   PubMedGoogle Scholar
• Hoshino, S., H. Miyazawa, T. Enomoto, F. Hanaoka, Y. Kikuchi, A. Kikuchi, and M. Ui. 1989. A human homologue of the yeast GST1 gene codes for a GTP-binding protein and is expressed in a proliferation-dependent manner in mammalian cells. EMBO J. 8:3807–3814.
   PubMedGoogle Scholar
• Hosoda, N., T. Kobayashi, N. Uchida, Y. Funakoshi, Y. Kikuchi, S. Hoshino, and T. Katada. 2003. Translation termination factor eRF3 mediates mRNA decay through the regulation of deadenylation. J. Biol. Chem. 278:38287–38291.
   PubMedGoogle Scholar
• Jakobsen, C. G., T. M. Segaard, O. Jean-Jean, L. Frolova, and J. Justesen. 2001. Identification of a novel termination release factor eRF3b expressing the eRF3 activity in vitro and in vivo. Mol. Biol. (Moscow) 35:672–681.
   PubMedGoogle Scholar
• Janzen, D. M., and A. P. Geballe. 2004. The effect of eukaryotic release factor depletion on translation termination in human cell lines. Nucleic Acids Res. 32:4491–4502.
   PubMed Web of Science ®Google Scholar
• Kikuchi, Y., H. Shimatake, and A. Kikuchi. 1988. A yeast gene required for the G1-to-S transition encodes a protein containing an A-kinase target site and GTPase domain. EMBO J. 7:1175–1182.
   PubMed Web of Science ®Google Scholar
• Kobayashi, T., Y. Funakoshi, S. Hoshino, and T. Katada. 2004. The GTP-binding release factor eRF3 as a key mediator coupling translation termination to mRNA decay. J. Biol. Chem. 279:45693–45700.
   PubMedGoogle Scholar
• Le Goff, X., M. Philippe, and O. Jean-Jean. 1997. Overexpression of human release factor 1 alone has an antisuppressor effect in human cells. Mol. Cell. Biol. 17:3164–3172.
   PubMedGoogle Scholar
• Ma, L., Z. Chen, H. Erdjument-Bromage, P. Tempst, and P. P. Pandolfi. 2005. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121:179–193.
   PubMed Web of Science ®Google Scholar
• Malta-Vacas, J., C. Aires, P. Costa, A. R. Conde, S. Ramos, A. P. Martins, C. Monteiro, and M. Brito. 2005. Differential expression of the eukaryotic release factor 3 (eRF3/GSPT1) according to gastric cancer histological types. J. Clin. Pathol. 58:621–625.
   PubMedGoogle Scholar
• Malumbres, M., and M. Barbacid. 2005. Mammalian cyclin-dependent kinases. Trends Biochem. Sci. 30:630–641.
   PubMed Web of Science ®Google Scholar
• Maquat, L. E. 2005. Nonsense-mediated mRNA decay in mammals. J. Cell Sci. 118:1773–1776.
   PubMed Web of Science ®Google Scholar
• Morley, S. J., and S. Naegele. 2002. Phosphorylation of eukaryotic initiation factor (eIF) 4E is not required for de novo protein synthesis following recovery from hypertonic stress in human kidney cells. J. Biol. Chem. 277:32855–32859.
   PubMed Web of Science ®Google Scholar
• Patino, M. M., J. J. Liu, J. R. Glover, and S. Lindquist. 1996. Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science 273:622–626.
   PubMed Web of Science ®Google Scholar
• Paushkin, S. V., V. V. Kushnirov, V. N. Smirnov, and M. D. Ter-Avanesyan. 1996. Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J. 15:3127–3134.
   PubMed Web of Science ®Google Scholar
• Petsch, K. A., J. Mylne, and J. R. Botella. 2005. Cosuppression of eukaryotic release factor 1-1 in Arabidopsis affects cell elongation and radial cell division. Plant Physiol. 139:115–126.
   PubMedGoogle Scholar
• Phillips-Jones, M. K., F. J. Watson, and R. Martin. 1993. The 3′ codon context effect on UAG suppressor tRNA is different in Escherichia coli and human cells. J. Mol. Biol. 233:1–6.
   PubMedGoogle Scholar
• Pisareva, V. P., A. V. Pisarev, C. U. Hellen, M. V. Rodnina, and T. V. Pestova. 2006. Kinetic analysis of interaction of eukaryotic release factor 3 with guanine nucleotides. J. Biol. Chem. 281:40224–40235.
   PubMedGoogle Scholar
• Pyronnet, S., and N. Sonenberg. 2001. Cell-cycle-dependent translational control. Curr. Opin. Genet. Dev. 11:13–18.
   PubMed Web of Science ®Google Scholar
• Roux, P. P., B. A. Ballif, R. Anjum, S. P. Gygi, and J. Blenis. 2004. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc. Natl. Acad. Sci. USA 101:13489–13494.
   PubMed Web of Science ®Google Scholar
• Salas-Marco, J., and D. M. Bedwell. 2004. GTP hydrolysis by eRF3 facilitates stop codon decoding during eukaryotic translation termination. Mol. Cell. Biol. 24:7769–7778.
   PubMed Web of Science ®Google Scholar
• Sarbassov, D. D., D. A. Guertin, S. M. Ali, and D. M. Sabatini. 2005. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307:1098–1101.
   PubMed Web of Science ®Google Scholar
• Stephens, L., K. Anderson, D. Stokoe, H. Erdjument-Bromage, G. F. Painter, A. B. Holmes, P. R. Gaffney, C. B. Reese, F. McCormick, P. Tempst, J. Coadwell, and P. T. Hawkins. 1998. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279:710–714.
   PubMed Web of Science ®Google Scholar
• Tallheden, T., C. Karlsson, A. Brunner, J. Van Der Lee, R. Hagg, R. Tommasini, and A. Lindahl. 2004. Gene expression during redifferentiation of human articular chondrocytes. Osteoarthritis Cartilage 12:525–535.
   PubMed Web of Science ®Google Scholar
• Tikhomirova, V. L., and S. G. Inge-Vechtomov. 1996. Sensitivity of sup35 and sup45 suppressor mutants in Saccharomyces cerevisiae to the anti-microtubule drug benomyl. Curr. Genet. 30:44–49.
   PubMedGoogle Scholar
• Uchida, N., S. Hoshino, H. Imataka, N. Sonenberg, and T. Katada. 2002. A novel role of the mammalian GSPT/eRF3 associating with poly(A)-binding protein in Cap/poly(A)-dependent translation. J. Biol. Chem. 277:50286–50292.
   PubMed Web of Science ®Google Scholar
• Valouev, I. A., V. V. Kushnirov, and M. D. Ter-Avanesyan. 2002. Yeast polypeptide chain release factors eRF1 and eRF3 are involved in cytoskeleton organization and cell cycle regulation. Cell Motil. Cytoskeleton 52:161–173.
   PubMed Web of Science ®Google Scholar
• Zhouravleva, G., L. Frolova, X. Le Goff, R. Le Guellec, S. Inge-Vechtomov, L. Kisselev, and M. Philippe. 1995. Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3. EMBO J. 14:4065–4072.
   PubMed Web of Science ®Google Scholar